Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths
about
Method dependence, observer variability and kidney volumes in radiation dosimetry of (177)Lu-DOTATATE therapy in patients with neuroendocrine tumours.Kidney dosimetry during 177Lu-DOTATATE therapy in patients with neuroendocrine tumors: aspects on calculation and tolerance.The efficacy of (177)Lu-labelled peptide receptor radionuclide therapy in patients with neuroendocrine tumours: a meta-analysis.
P2860
Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths
description
article
@en
im Oktober 2014 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2014
@uk
name
Whither peptide receptor radio ...... an view of the facts and myths
@en
Whither peptide receptor radio ...... an view of the facts and myths
@nl
type
label
Whither peptide receptor radio ...... an view of the facts and myths
@en
Whither peptide receptor radio ...... an view of the facts and myths
@nl
prefLabel
Whither peptide receptor radio ...... an view of the facts and myths
@en
Whither peptide receptor radio ...... an view of the facts and myths
@nl
P2093
P2860
P1476
Whither peptide receptor radio ...... an view of the facts and myths
@en
P2093
Irvin M Modlin
Lisa Bodei
Vikas Prasad
P2860
P2888
P304
P356
10.1007/S00259-014-2780-0
P407
P577
2014-10-01T00:00:00Z